DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

May 3, 2023

Study Completion Date

May 3, 2023

Conditions
Trypanosomiasis, African
Interventions
DRUG

Acoziborole

Acoziborole 960 mg (three tablets of 320 mg) for oral route in fasted condition Period 2: single oral administration on Day 12

DRUG

Midazolam

• Midazolam 5 mg syrup in fasted condition Period 1: Single oral dose of 5 mg administered on Day 8 Period 2: Single oral dose of 5 mg administered on Day 21

DRUG

Dextromethorphan

• Dextromethorphan 15 mg syrup in fasted condition Period 1: Single oral dose of 15 mg administered on Day 1 Period 2: Single oral dose of 15 mg administered on Day 14

Trial Locations (1)

Unknown

Clinical Research Center (CRC) Ampang Hospital, Kuala Lumpur

All Listed Sponsors
lead

Drugs for Neglected Diseases

OTHER